X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17) 17
humans (16) 16
hematology (11) 11
animals (9) 9
mice (9) 9
cancer (8) 8
multiple myeloma (8) 8
analysis (6) 6
antineoplastic agents - pharmacology (6) 6
lymphomas (6) 6
mice, scid (6) 6
cell line, tumor (5) 5
cells (5) 5
female (5) 5
male (5) 5
multiple myeloma - drug therapy (5) 5
multiple myeloma - metabolism (5) 5
multiple myeloma - pathology (5) 5
xenograft model antitumor assays (5) 5
abridged index medicus (4) 4
aged (4) 4
aged, 80 and over (4) 4
cell proliferation - drug effects (4) 4
chemotherapy (4) 4
lymphoma (4) 4
middle aged (4) 4
multiple myeloma - genetics (4) 4
oncology (4) 4
tumors (4) 4
adult (3) 3
agriculture (3) 3
animal husbandry (3) 3
antineoplastic agents - therapeutic use (3) 3
antitumor-activity (3) 3
beer (3) 3
biochemistry (3) 3
care of birds, fishes, insects (3) 3
case-control studies (3) 3
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (3) 3
chemistry (3) 3
compositions thereof (3) 3
culture media (3) 3
disinfection, sterilisation, or deodorisation of air (3) 3
dose-response relationship, drug (3) 3
enzymology (3) 3
fishing (3) 3
forestry (3) 3
gene expression profiling (3) 3
gene expression regulation, neoplastic (3) 3
genetic aspects (3) 3
human necessities (3) 3
hunting (3) 3
hygiene (3) 3
lymphoid neoplasia (3) 3
materials for bandages, dressings, absorbent pads, or surgicalarticles (3) 3
medical or veterinary science (3) 3
metallurgy (3) 3
methods or apparatus for sterilising materials or objects ingeneral (3) 3
microbiology (3) 3
microorganisms or enzymes (3) 3
multiple-myeloma (3) 3
mutation or genetic engineering (3) 3
neoplasm recurrence, local - drug therapy (3) 3
new breeds of animals (3) 3
non-hodgkin-lymphoma (3) 3
prognosis (3) 3
propagating, preserving or maintaining microorganisms (3) 3
rearing or breeding animals, not otherwise provided for (3) 3
rituximab (3) 3
signal transduction (3) 3
spirits (3) 3
transplantation (3) 3
trapping (3) 3
treatment outcome (3) 3
tumor cells, cultured (3) 3
vinegar (3) 3
wine (3) 3
acrylamides - pharmacology (2) 2
apoptosis (2) 2
apoptosis - drug effects (2) 2
article (2) 2
autologous stem cell transplant (2) 2
autophagy - drug effects (2) 2
blotting, western (2) 2
bone marrow - metabolism (2) 2
bone marrow - pathology (2) 2
bone-marrow (2) 2
boronic acids - pharmacology (2) 2
bortezomib (2) 2
care and treatment (2) 2
cell movement (2) 2
cell proliferation (2) 2
central nervous system (2) 2
clarithromycin (2) 2
diffuse large b-cell lymphoma (2) 2
disease (2) 2
doxorubicin (2) 2
drug therapy (2) 2
drug-resistance (2) 2
drugs (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Cycle, ISSN 1538-4101, 12/2013, Volume 12, Issue 23, pp. 3650 - 3662
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2908 - 2908
Introduction Primary adrenal lymphoma (PAL) and primary renal lymphoma (PRL) are rare extranodal lymphomas, predominantly of diffuse large B-cell lymphoma... 
Journal Article
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2011, Volume 7, Issue 6, pp. 955 - 964
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4725 - 4725
Abstract Multiple myeloma (MM) is a plasma cell malignancy which remains incurable despite novel therapeutic approaches targeting both myeloma cells and their... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 4451 - 4451
MicroRNAs (miRNAs) are short non-coding RNAs that control gene expression at the post-transcriptional level by inducing mRNA decay or translation repression. A... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 2060 - 2060
Abstract Gene transcription within the tumor cell and its microenvironment can be affected by epigenetic modulation in histones and inhibition of histone... 
Journal Article
Blood, ISSN 0006-4971, 12/2012, Volume 120, Issue 25, pp. 5002 - 5013
Journal Article
Blood, ISSN 0006-4971, 10/2012, Volume 120, Issue 17, pp. 3519 - 3529
Malignant cells have a higher nicotinamide adenine dinucleotide (NAD(+)) turnover rate than normal cells, making this biosynthetic pathway an attractive target... 
MAMMALIAN TARGET | RAPAMYCIN | METABOLISM | BONE-MARROW | NAMPT | DEPLETION | ANTITUMOR-ACTIVITY | HEMATOLOGY | CANCER | NICOTINAMIDE ADENINE-DINUCLEOTIDE | MOLECULAR-MECHANISMS | RNA, Small Interfering - genetics | Humans | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Multiprotein Complexes | Molecular Targeted Therapy | Nicotinamide Phosphoribosyltransferase - antagonists & inhibitors | Autophagy - drug effects | Mechanistic Target of Rapamycin Complex 1 | Dose-Response Relationship, Drug | Multiple Myeloma - drug therapy | Nicotinamide Phosphoribosyltransferase - metabolism | Piperidines - pharmacology | Mitogen-Activated Protein Kinase 1 - genetics | Antineoplastic Agents - pharmacology | NAD - antagonists & inhibitors | Autophagy - genetics | Gene Expression Regulation, Neoplastic - drug effects | Acrylamides - pharmacology | Cytokines - genetics | NAD - metabolism | Cytokines - metabolism | Mitogen-Activated Protein Kinase 3 - genetics | Cell Survival | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Enzyme Inhibitors - pharmacology | Signal Transduction - genetics | Multiple Myeloma - metabolism | Organ Specificity | Proteins - genetics | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Nicotinamide Phosphoribosyltransferase - genetics | Animals | Proteins - metabolism | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Cell Line, Tumor | Mice | TOR Serine-Threonine Kinases | Cytokines - antagonists & inhibitors | Proteins - antagonists & inhibitors | Multiple Myeloma - genetics | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Lymphoid Neoplasia
Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 04/2019, Volume 39, Issue 4, pp. 679 - 684
Purpose: To detect the presence of MYD88 L265P mutation in the aqueous humor of patients with cytologically proven vitreoretinal lymphoma. Methods: Eight... 
anterior chamber paracentesis | DIAGNOSIS | MYD88 L265P mutation | vitreoretinal lymphoma | OPHTHALMOLOGY | INTRAOCULAR LYMPHOMA | SOMATIC MUTATION | aqueous humor | primary central nervous system lymphoma | NERVOUS-SYSTEM LYMPHOMA | Gene mutations | Genetic aspects | Lymphomas | Aqueous humor | Diagnosis | Health aspects | Retinal diseases
Journal Article